GoKawiilAcorn Biolabs founder details AI-driven stem cell aging research
In an episode of Adventures in AI, Acorn Biolabs founder Drew Taylor discussed how his company applies artificial intelligence to regenerative medicine, including using image analysis to predict stem cell performance and designing biologically tailored treatment plans. The conversation also touched on societal and financial implications of extended human lifespans.